|
|
|
|
|
||
|
|
|
|
|
|
Stimulation of the vagus nerve in the left cervical region
is an FDA approved technique for treating epilepsy. Approximately
30,000 people have VNS devices implanted for seizure control. In
1998, BLS researchers at MUSC were
the first in the world to implant
VNS devices in patients with major depression who had not
adequately
responded to traditional antidepressants. This multi-site open clinical
trial showed promising results. The BSL recently completed enrollment
in a followup multisite double-blind clinical trial of VNS in
refractory
depression.
We do offer VNS as a treatment for depression through our Mood Disorders Clinic. In addition, there are several ongoing add-on VNS studies at MUSC for patients who are interested. These involve assessing quality of life, participating in a national registry, or determining whether VNS modulation of your pain threshold might help determine optimum dosing. |
|